Effekten af BID- regimet er evalueret overfor TID- regimet med VIRACEPT 250 mg tabletter, hovedsageligt hos PI- naive patienter.
The efficacy of the BID regimen has been evaluated versus the TID regimen with VIRACEPT 250 mg tablets primarily in patients naïve to PIs.